SYMDEKO 100mg/150mg + 150mg cpr pell 56 pce
7680667420019
CH-66742
R07AX31
03.99.0.
Active substances:
1 / 3
google
Details
- Product number
- 6674201
- CPT
- -
- Packaging group
- 56 (4 x 14)
- Unit
- Tablette(n)
- Composition
- Filmtablette Morgendosis (tezacaftorum 100 mg / ivacaftorum 150 mg): tezacaftorum 100 mg, ivacaftorum 150 mg, hypromellosi acetas succinas, natrii laurilsulfas, hypromellosum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, talcum, E 171, E 172 (flavum) pro compresso obducto corresp. natrium 2.74 mg. Filmtablette Abenddosis (ivacaftorum 150 mg): ivacaftorum 150 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 167.2 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 132, cera carnauba, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 1.82 mg.
Articles (1)
Symdeko 100 mg / 150 mg und 150 mg, Filmtabletten
Filmtabletten
56 (4 x 14)
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
tezacaftorum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
ivacaftorum
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
ivacaftorum
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
167.2 MG | Substance | HBESI |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 132
|
- | Substance | FIMDK |
|
cera carnauba
|
- | Substance | HNIDK |
|
natrium
|
2.74 MG | Substance | HBESI |
|
lacca
|
- | Substance | HNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
propylenglycolum
|
- | Substance | HBESI |
|
ammonii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
1.82 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 11126.70
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2020
Authorization holder
Vertex Pharmaceuticals (CH) GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 66742
- Drug name
- Symdeko, Filmtabletten
- Galenic form
- FILM
- ATC Code
- R07AX31
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/05/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 03.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SYMDEKO 100mg/150mg + 150mg cpr pell 56 pce
- Description (DE)
- SYMDEKO 100mg/150mg + 150mg Filmtabl 56 Stk
- Market launch
- 10/05/2019
- Narcotic (BTM)
- No